Entyvio (vedolizumab)

Manufacturer:

Takeda

Route of Administration:

Intravenous, Subcutaneous

Site of Care:

Outpatient

Website:

Manufacturer Website

phone:

1-855-ENTYVIO (1-855-368-9846)

Enrollment Forms:

Synergen Prescription Form

Patient Support Form

Approved Indication:

treatment of moderately to severely active ulcerative colitis
treatment of moderately to severely active Crohn’s disease

Conditions:

Crohn’s Disease
Ulcerative Colitis

Therapeutic Area:

Gastroenterology